Biohaven Pharmaceutical Holding Co Ltd.

Ensign Peak Advisors, Inc

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

102,726

Value ($000)

15,529

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	15,529	0.0%	102,726	9/30/2022
2022 Q2	8/12/2022	14,968	0.0%	102,726	6/30/2022
2022 Q1	5/16/2022	16,213	0.0%	136,740	3/31/2022
2021 Q4	2/11/2022	16,870	0.0%	122,413	12/31/2021
2021 Q3	11/12/2021	12,987	0.0%	93,492	9/30/2021
2021 Q2	8/13/2021	7,714	0.0%	79,461	6/30/2021
2021 Q1	5/12/2021	4,498	0.0%	65,808	3/31/2021
2020 Q4	2/12/2021	3,110	0.0%	36,286	12/31/2020
2020 Q3	11/12/2020	2,358	0.0%	36,286	9/30/2020
2020 Q2	8/12/2020	4,718	0.0%	64,542	6/30/2020
2020 Q1	5/11/2020	1,568	0.0%	46,073	3/31/2020
2019 Q4	2/14/2020	1,384	0.0%	25,426	12/31/2019